Contract facts
FederalNo full NAICS 325413 intel page yet. Browse NAICS intelligence
RAPID AUTOMATED MULTIPLEX PCR DIAGNOSTICS FOR PATHOGEN TESTING REAGENTS, TEST KITS, TEST SETS AND SUPPLIES. is a federal award for 252-Network Contract Office 12 (36C252) held by Biofire Diagnostics, LLC. Estimated value $143K ($143K obligated). Current period of performance ends Sep 30, 2022. Place of performance: SALT LAKE CITY UT.
RAPID AUTOMATED MULTIPLEX PCR DIAGNOSTICS FOR PATHOGEN TESTING REAGENTS, TEST KITS, TEST SETS AND SUPPLIES.
Recompete timing
PublicCurrent PoP ended Sep 30, 2022 (1421 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordBiofire Diagnostics, LLC — $14.7M obligated across 200 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25222N0032?
36C25222N0032 (RAPID automated multiplex PCR diagnostics for) is a 252-Network Contract Office 12 (36C252) award with a potential value of $143K, currently held by Biofire Diagnostics, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C252-22-N-0032?
36C252-22-N-0032 is the dashed form of PIID 36C25222N0032 (RAPID automated multiplex PCR diagnostics for), held by Biofire Diagnostics, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25222N0032?
252-Network Contract Office 12 (36C252) awarded 36C25222N0032 to Biofire Diagnostics, LLC (potential $143K).
Who is the incumbent on 36C25222N0032?
Biofire Diagnostics, LLC is the incumbent with $14.7M across 200 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2022.
When does Biofire Diagnostics, LLC’s 36C25222N0032 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.